SIREN : 340602143
COSMEPHARM is a French company founded 39 years ago, specialized in the sector Activités de conditionnement. Based in VARENNES SUR ALLIER (03150), this company of category PME shows in 2020 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | N/C | 1 136 628 € | N/C | 848 231 € | 838 876 € | 958 167 € |
| Net income | 663 433 € | 364 844 € | 50 209 € | 137 700 € | 306 249 € | 11 922 € | 229 371 € | -379 158 € | -11 890 € |
| EBITDA | N/C | N/C | N/C | N/C | 270 306 € | N/C | -83 420 € | -194 553 € | 1 453 € |
| Net margin | N/C | N/C | N/C | N/C | 26.9% | N/C | 27.0% | -45.2% | -1.2% |
In 2024, COSMEPHARM generates positive net income of 663 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
663 433 €
The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
31.346%
39.046%
32.3%
In 2024, the debt ratio of COSMEPHARM (31.35) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of COSMEPHARM (39.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
The liquidity ratio (= Current assets / Current liabilities) stands at 173.87. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
173.869
In 2024, the liquidity ratio of COSMEPHARM (173.87) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 158 transactions of similar company sales (all years), the value of COSMEPHARM is estimated at 2 172 170 € (range 581 720€ - 5 269 400€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 158 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare COSMEPHARM with other companies in the same sector:
Voir toutes les statistiques du secteur Activités de conditionnement
The revenue of COSMEPHARM in 2020 is 1.1 M€.
Yes, COSMEPHARM generated a net profit of 663 k€ in 2024.
The headquarters of COSMEPHARM is located in VARENNES SUR ALLIER (03150), in the department Allier.
The tax return of COSMEPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
COSMEPHARM operates in the sector Activités de conditionnement (NAF code 82.92Z). See the 'Sector positioning' section above to compare the company with its competitors.